Immune‐mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report

Documenti analoghi

• Risk factors for silent cerebral infarction in immune‐mediated thrombotic thrombocytopenic survivors
  di: Binish Javed, et al.
  Pubblicazione: (2025)
• Facing the bleeding risk of caplacizumab in postpartum immune thrombotic thrombocytopenic purpura in constrained resource settings
  di: José Rojas‐Suarez, et al.
  Pubblicazione: (2025)
• Successful management of refractory immune‐mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti‐VWF nanobody caplacizumab
  di: Roman R. Schimmer, et al.
  Pubblicazione: (2024)
• Warm autoimmune haemolytic anaemia: Clinical considerations
  di: Irina Murakhovskaya, et al.
  Pubblicazione: (2026)
• A decade of pharmacovigilance in France: Immune checkpoints join the list of usual suspects for drug‐induced immune haemolytic anaemia
  di: Guillaume Brenac, et al.
  Pubblicazione: (2025)